S. 854 · 119th Congress · Health

Risky Research Review Act

Establishes review procedures for federally funded research with potential dual-use risks. AI-read

Out of committee7.1k words Introduced Mar 5, 2025 · Latest action Sep 17, 2025

How far it has goneStage 3 of 6
  1. IntroducedMar 5, 2025 Done
  2. CommitteeReported Sep 17, 2025 Done
  3. Senate floorAwaiting vote Current stage
  4. House floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research. High-risk life sciences research means the study of an organism, virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or virulence of certain high-risk pathogens (e.g., Ebola).

Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review.

In making its determinations, the board must consider specified factors, including whether the benefits of the research outweigh the risks. The bill prohibits agencies from awarding federal funding for high-risk life sciences research without approval of the board or for life sciences research currently under board review. The board may also review awards that were made before the bill’s enactment.

Entities that fail to properly attest to the nature of their research may lose their eligibility for funding. Additionally, agency employees who fail to comply with the bill's requirements are subject to disciplinary action.

Congressional Research Service · summary of “Introduced in Senate” version · Mar 5, 2025

Who lobbies on it

1 organization · 1 filing · Q1 2025–Q3 2026

See which of this bill’s sponsors and cosponsors got money from Biotechnology Innovation Organization’s PAC → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. Biotechnology Innovation Organization 1 of 7 quarters
    “340B Drug Discount Program ---Executive Order on Access to Affordable Life-Saving Medications ---Program & Oversight Accelerated Approval Artificial Intelligence (AI) Alternative Funding Programs Biodefense Research, Development and Procurement Issues (Non-Funding) ---S.854 Risky Research Review Act ---Bio COMPETES…”

    $5.6M lobbying spend in 2025, all issuesQ1 2025 filing

Organizations that named S. 854 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

5 actions · newest first
  1. Sep 17, 2025Placed on Senate Legislative Calendar under General Orders. Calendar No. 164.
  2. Sep 17, 2025Committee on Homeland Security and Governmental Affairs. Reported by Senator Paul without amendment. Without written report.
  3. Jul 30, 2025Committee on Homeland Security and Governmental Affairs. Ordered to be reported without amendment favorably.
  4. Mar 5, 2025Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Show all 5 actionsShow fewer
  1. Mar 5, 2025Introduced in Senate